Table of Content


1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Gummy Vitamins Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type
6.1 Single Vitamin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Multi Vitamin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Prebiotics and Probiotics
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Demographics
7.1 Children
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Adult
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Sales Channel
8.1 Supermarkets and Hypermarkets
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Speciality Stores
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Retail Pharmacies
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Online Stores
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Bayer AG
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bettera Wellness LLC
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Church & Dwight Co. Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Hero Nutritionals
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Ion Labs Inc. (DCC plc)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Nature’s Way Products LLC. (Dr. Willmar Schwabe GmbH & Co. KG)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Pfizer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pharmavite (Otsuka Pharmaceutical Co. Ltd)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Santa Cruz Nutritionals
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 SmartyPants Vitamins (Unilever plc)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 The Honest Company Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Vitakem Nutraceutical Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio